Baxter International Inc
(XSWX:BAX)
CHF
54.5
0 (0%)
Market Cap: 17.43 Bil
Enterprise Value: 26.92 Bil
PE Ratio: 147.10
PB Ratio: 1.91
GF Score: 65/100 Baxter International Inc at UBS Global Healthcare Virtual Conference Transcript
May 25, 2021 / 06:00PM GMT
Release Date Price:
CHF84
Matthew Charles Taylor
UBS Investment Bank, Research Division - Equity Research Analyst of Medical Supplies & Devices
Okay. Good afternoon, and welcome to our next session here in the medtech track of the UBS Global Healthcare Conference. I'm Matt Taylor, the U.S. Medical Supplies and Devices Analyst for UBS. And I'm really pleased to be joined by the management team from Baxter. And today, we have 2 special guests, Jay Saccaro, the EVP and CFO of Baxter; and Clare Trachtman, VP of Investor Relations.
Jay and Clare, thanks a lot for joining us, and welcome to the webcast.
James K. Saccaro
Baxter International Inc. - Executive VP & CFO
Matt, thanks very much. It's nice to meet you as always. This year, virtually, maybe next year, we'll get to meet in person.
Matthew Charles Taylor;
UBS Investment Bank, Research Division - Equity Research Analyst of Medical Supplies & Devices
We're getting there, hopefully soon, we'll keep our fingers crossed for Laguna in August. Let's hope.
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot